Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial disorders

C T Moraes1

  • 1Department of Neurology, University of Miami, FL 33136, USA.

Current Opinion in Neurology
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Mitochondrial DNA mutations are linked to numerous neuromuscular and other disorders, affecting aging and neurodegeneration. Despite extensive research, effective treatments for mitochondrial diseases remain limited.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth.

Nature communications·2020
Same author

DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.

Journal of internal medicine·2020
Same author

Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease.

Gene therapy·2011
Same author

Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease.

Gene therapy·2010
Same author

Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies.

Gut·2007
Same author

Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model.

Gene therapy·2007
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Mitochondrial DNA (mtDNA) mutations were first identified in neuromuscular syndromes eight years ago.
  • The study of mitochondrial disorders has rapidly expanded beyond neurology to encompass multiple medical fields.

Purpose of the Study:

  • To review the expanding scope of mitochondrial DNA mutations and their associated disorders.
  • To highlight the implications of mtDNA mutations in both inherited diseases and age-related conditions.

Main Methods:

  • Literature review and synthesis of current research on mitochondrial DNA mutations.
  • Analysis of associations between mtDNA mutations and various clinical manifestations.

Main Results:

Related Experiment Videos

  • Dozens of mtDNA mutations are now linked to neuromuscular, ophthalmologic, endocrinologic, gastrointestinal, and psychiatric disorders.
  • Potentially pathogenic mtDNA mutations are also implicated in normal aging and age-related neurodegenerative diseases.
  • Conclusions:

    • Mitochondrial disorders represent a significant and growing area of medical research.
    • Despite advances in understanding, therapeutic strategies for mitochondrial diseases are still in early stages.